Exoxemis is focused on the development of haloperoxidase enzyme-based
products to address the increasing threat of serious and drug-resistant
infections. We are committed to:
- Leveraging expertise in enzymology, bioanalytical methods, microbiology,
and formulation sciences to bring new products to market.
- Applying highest quality science, research, and development to our
partnerships and collaborations.
- Supporting scholarship and innovation in evolving applications of
- Targeting product opportunities to address areas of high, unmet clinical
demand, and strong potential market growth.
- Extending the application of the myeloperoxidase and eosinophil peroxidase
technology platform to a wide variety of medical, veterinary, agricultural,
disinfectant, and industrial applications.
- Offering flexibility in formulation to accommodate multiple indications
and provide a cGMP-manufactured product
- Delivering value to partners and collaborators.